Cargando…

Utility of (18)F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer

PURPOSE: The aim of present study was to investigate the efficiency of (18)F-FDG uptake in predicting major pathological response (MPR) in resectable non-small cell lung cancer (NSCLC) patients with neoadjuvant immunotherapy. METHODS: A total of 104 patients with stage I-IIIB NSCLC were retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaowei, Bai, Guangyu, Zang, Ruochuan, Song, Peng, Bie, Fenglong, Huai, Qilin, Li, Yuan, Liu, Yang, Zhou, Bolun, Bie, Yifan, Yang, Zhenlin, Gao, Shugeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339250/ https://www.ncbi.nlm.nih.gov/pubmed/37421908 http://dx.doi.org/10.1016/j.tranon.2023.101725

Ejemplares similares

Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study
por: Zhou, Bolun, et al.
Publicado: (2023)

RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer
por: Zhou, Bolun, et al.
Publicado: (2022)

Global burden and temporal trends in incidence and mortality of oesophageal cancer
por: Zhou, Bolun, et al.
Publicado: (2022)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
por: Peng, Yue, et al.
Publicado: (2022)

Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
por: Zhou, Bolun, et al.
Publicado: (2022)

A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes
por: Zhou, Bolun, et al.
Publicado: (2022)

Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians
por: Bie, Fenglong, et al.
Publicado: (2021)

Single‐cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer
por: Guo, Wei, et al.
Publicado: (2023)

Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization
por: Bie, Fenglong, et al.
Publicado: (2023)

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial: A randomized clinical trial of neoadjuvant therapy for ESCC
por: Li, Yong, et al.
Publicado: (2023)

Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma
por: Zhao, Liang, et al.
Publicado: (2022)

The efficiency of (18)F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
por: Tao, Xiuli, et al.
Publicado: (2020)

Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis
por: Yan, Tao, et al.
Publicado: (2019)

Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma
por: Guo, Wei, et al.
Publicado: (2022)

Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET/CT scan
por: Ju, Huijun, et al.
Publicado: (2017)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
por: Yang, Zhenlin, et al.
Publicado: (2021)

Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysis
por: Xu, Jun, et al.
Publicado: (2019)

[18F] FDG uptake: pay attention to candies
por: Travaini, LL, et al.
Publicado: (2007)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT
por: Dong, Aisheng, et al.
Publicado: (2016)

Can physiologic colonic [(18)F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for resectable esophageal cancer: A review
por: Li, Qing, et al.
Publicado: (2022)

Gut microbiota and physiologic bowel (18)F-FDG uptake
por: Kang, Ji Yeon, et al.
Publicado: (2017)

Intrapatient variability of 18F-FDG uptake in normal tissues
por: Sayed, Mohamed Hosny Mohamed, et al.
Publicado: (2022)

Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression
por: Feng, Feiyue, et al.
Publicado: (2017)

The reduction of (18)F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression
por: Wu, Fengpeng, et al.
Publicado: (2022)

Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by (18)F-FDG PET/CT Imaging
por: Vlachopoulos, Charalambos V., et al.
Publicado: (2020)

Dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer
por: Chen, Zhi‐Yong, et al.
Publicado: (2022)

Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)

Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis
por: Xu, Jiawei, et al.
Publicado: (2022)

Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
por: Chen, Lanyi Nora, et al.
Publicado: (2023)

Uptake of (18)FDG by a Hepatic Adenoma on Positron Emission Tomography
por: Stephenson, J. A., et al.
Publicado: (2011)

Lung inhomogeneities, inflation and [(18)F]FDG uptake rate in ards
por: Cressoni, M, et al.
Publicado: (2015)

Genetic features associated with (18)F-FDG uptake in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2019)

Cardiac 18F‑FDG uptake and new‑onset rectal cancer
por: Sawaragi, Kazuhito, et al.
Publicado: (2023)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

Neoadjuvant immunotherapy facilitates resection of surgically-challenging lung squamous cell cancer
por: Xu, Ke, et al.
Publicado: (2021)

Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, (18)F-FDG PET/MRI and CA 19–9
por: Yoo, Jeongin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1hhqcujbvl8q3dihg82tms4rr2